##gff-version 3
##sequence-region P43355 1 309
P43355	UniProtKB	Chain	1	309	.	.	.	ID=PRO_0000156701;Note=Melanoma-associated antigen 1	
P43355	UniProtKB	Domain	102	301	.	.	.	Note=MAGE;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00127	
P43355	UniProtKB	Compositional bias	33	36	.	.	.	Note=Poly-Ser	
P43355	UniProtKB	Modified residue	57	57	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
P43355	UniProtKB	Natural variant	32	32	.	.	.	ID=VAR_004283;Note=Probable polymorphism. T->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15059299,ECO:0000269|PubMed:15489334,ECO:0000269|Ref.4;Dbxref=dbSNP:rs2008160,PMID:15059299,PMID:15489334	
P43355	UniProtKB	Natural variant	63	63	.	.	.	ID=VAR_053491;Note=A->T;Dbxref=dbSNP:rs2233044	
P43355	UniProtKB	Natural variant	72	72	.	.	.	ID=VAR_011737;Note=R->Q;Dbxref=dbSNP:rs2008144	
P43355	UniProtKB	Natural variant	278	278	.	.	.	ID=VAR_036581;Note=In a breast cancer sample%3B somatic mutation. K->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=PMID:16959974	
P43355	UniProtKB	Mutagenesis	163	163	.	.	.	Note=Abolishes HLA-A1 binding. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8113684;Dbxref=PMID:8113684	
P43355	UniProtKB	Mutagenesis	169	169	.	.	.	Note=Abolishes HLA-A1 binding. Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8113684;Dbxref=PMID:8113684	
